X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Pulmonary Circulation

期刊標題檢索 PULM CIRC 最新評論: Research focus: Pulmonary arterial hypertension; Experience sharing o... (2024-07-02)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Pulmonary Circulation]您好,您是該頁面的第 14077 位訪客。

期刊簡介
期刊名稱Pulmonary Circulation Pulmonary Circulation
LetPub Score
5.1
50 ratings
Rate

Reputation
5.8

Influence
3.8

Speed
9.1

期刊簡稱PULM CIRC
ISSN2045-8932
E-ISSN2045-8940
h-index32
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.200.7610.773
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pulmonary and Respiratory Medicine
Q270 / 155

自引率 (2023-2024)9.10%自引率趨勢
掲載範囲
Pulmonary Circulation's main goal is to encourage basic, translational, and clinical research by investigators, physician-scientists, and clinicans, in the hope of increasing survival rates for pulmonary hypertension and other pulmonary vascular diseases worldwide, and developing new therapeutic approaches for the diseases. Freely available online, Pulmonary Circulation allows diverse knowledge of research, techniques, and case studies to reach a wide readership of specialists in order to improve patient care and treatment outcomes.
官方網站https://journals.sagepub.com/home/pul
在線稿件提交https://mc.manuscriptcentral.com/pulmonarycirculation
開放訪問Yes
出版商SAGE Publications Inc.
主題領域Medicine
出版國/地區UNITED STATES
發行頻率
創刊年0
每年文章數134每年文章數趨勢
黃金OA百分比75.25%
OA Related Info
APC: Yes( USD2310; GBP1730; EUR1940; )
APC waiver:Check Notes
Other charges: No
Keywords: pulmonary circulation、hypertension、vascular disease、cardiopulmonary disease
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CARDIAC & CARDIOVASCULAR SYSTEMSSCIEQ2110/220
RESPIRATORY SYSTEMSCIEQ356/100
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2045-8932%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 15 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Pulmonary Circulation】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PulmonologyH-index: 0

    CiteScore: 14.30
    European Respiratory ReviewH-index: 0

    CiteScore: 14.40
    ARCHIVOS DE BRONCONEUMOLOGIAH-index: 46

    CiteScore: 3.50
    Annals of the American Thoracic SocietyH-index: 0

    CiteScore: 10.00
    ERJ Open ResearchH-index: 0

    CiteScore: 6.20
    Seminars in Thoracic and Cardiovascular SurgeryH-index: 0

    CiteScore: 5.80
    Pulmonary TherapyH-index: 0

    CiteScore: 5.20
    Multidisciplinary Respiratory MedicineH-index: 18

    CiteScore: 4.40
    Journal of Clinical Tuberculosis and Other Mycobacterial DiseasesH-index: 0

    CiteScore: 4.00
    Current Sleep Medicine ReportsH-index: 0

    CiteScore: 2.50
    學科內最受檢索的期刊 頁面查看次數
    Annals of the American Thoracic Society12598
    Pulmonology11767
    European Respiratory Review10714
    ARCHIVOS DE BRONCONEUMOLOGIA10080
    General Thoracic and Cardiovascular Surgery9360
    Multidisciplinary Respiratory Medicine7214
    ERJ Open Research6481
    Seminars in Thoracic and Cardiovascular Surgery5106
    Chinese Journal of Lung Cancer1979
    Open Respiratory Archives1677
  •  

    Pulmonary Circulation Pulmonary Circulation
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Pulmonary Circulation] 的評論撰寫評論
作者: 风芹小哥哥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-02 11:42:07 評論於
Research focus: Pulmonary arterial hypertension; Experience sharing on pulmonary hypertension: One meta-analysis, already revised three times majorly and once minorly, currently awaiting final decision for a week. Previously, one reviewer was unfriendly and the journal has been delaying the final decision, giving a bad feeling. Hopefully, it won't be dragged on for too long. If they don't want it, it's better to reject it early.
(0) 讚! | 风芹小哥哥

作者: 风芹小哥哥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-02 09:53:18 評論於
The representative is currently selecting reviewers, and the next step will be awaiting reviewer invitation.
(0) 讚! | 风芹小哥哥

作者: 葵花锦华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-23 21:44:08 評論於
What does "awaiting review selection" mean? Does it mean it hasn't been submitted for review yet?
(0) 讚! | 葵花锦华

作者: 葵花锦华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-21 23:55:09 評論於
How long has it been going on?
(0) 讚! | 葵花锦华

作者: 葵花锦华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-21 18:39:33 評論於
How long has it been going on?
(0) 讚! | 葵花锦华

作者: 葵花锦华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-07 09:06:50 評論於
Have you accepted?
(0) 讚! | 葵花锦华

作者: 魂魄瑞霞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-09 23:18:22 評論於
Review speed: 12.0 | Submission hit rate: 75.0
Emphasis on research direction: PE
Experience sharing: Submitted in May, accepted today, accepted after two major revisions, editor is very good
(0) 讚! | 魂魄瑞霞

作者: 易筋初风


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-21 21:50:56 評論於
How long does it take to await reviewer selection? It has been 2 weeks since submission and it is still in this state
(0) 讚! | 易筋初风

作者: 东风谷雪磊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-02 19:38:14 評論於
Have you submitted your manuscript for review? How long does the first review usually take?
(0) 讚! | 东风谷雪磊

作者: 八卦世昌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-05 16:31:53 評論於
Please translate the following passage into English and Japanese, with titles ":" and ":":

3.017
(0) 讚! | 八卦世昌

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 12:23:55 評論於
The discussion section is the core part of a SCI paper, as it can demonstrate the breadth and depth of the author's research. Therefore, there is no specific limit on the number of words in this section. Different articles and authors have varying lengths for the discussion section, with some being a few thousand words and others being tens of thousands of words
(0) 讚! | 维尔娜菲茨杰拉德

作者: 魂魄彦露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 11:36:47 評論於
Is the extensive discussion showing the author's reflection on the topic? Are the reviewers impressed by the manuscript?
(0) 讚! | 魂魄彦露

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 10:33:18 評論於
What is IF?
(0) 讚! | 陶宜三岁啦

作者: Elroy Houston


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-17 13:26:12 評論於
Review speed: 2.0 | Submission hit rate: 50.0
Main research direction: Pulmonary arterial hypertension
Experience sharing: Successfully published a paper in 2020, recently received a notification of acceptance for another paper, but the publisher has changed, please let me know if you are aware of this
(0) 讚! | Elroy Houston

作者: 八卦世昌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-13 22:37:31 評論於
How long does the review process take?
(0) 讚! | 八卦世昌

作者: 晨风盼菡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-10-27 11:16:32 評論於
Review speed: 2.0 | Acceptance rate: 50.0
Experience sharing: This is a journal that I feel very good about. I submitted a meta related to pulmonary vascular diseases, underwent major revision once and minor revision once, and then it was accepted. However, there is an APC fee
(0) 讚! | 晨风盼菡

作者: bba


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2018-08-22 16:39:27 評論於
There are a lot of good cardiovascular journals, and this is a very common journal. If you want to select a journal based on a high score, consider this one.

(0) 讚! | bba

作者: 云来初文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-08-22 10:41:33 評論於
There are many good journals on cardiovascular, this one can only be considered as a very ordinary journal. If you want to publish high-quality papers, consider switching to a different one
(0) 讚! | 云来初文

作者: 南川柔绚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-21 09:58:02 評論於
I just want to add an IF
(0) 讚! | 南川柔绚

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Pulmonary Circulation] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*